Brian Garsson
Chief Executive Officer
Precision medicine was never limited by the availability of data, it’s limited by whether a clinician can trust it and act on it at the moment of decision.
Aggregating data is the easy part. Our Context Engine assembles the whole patient, cited to the source. Our Digital Twin reasons over it with the restraint a tumor board would demand. And Loop Engineering keeps it true as the patient changes.
We don’t sell the data. We deliver the decision, the right therapy, for this patient, recalibrated at every step.
Our Digital Twin simulates therapy before a single dose, so every oncologist can act on evidence they trust, and more patients reach the right treatment sooner.
patient clinical validation, with a 10-oncologist accuracy review
Deep Precision™ NGS panels validated: breast, GI, colon, lung, ovarian
oncologists engaged across India
patents filed, plus a published PCT application
PROVEN SCIENCE
Peer-reviewed in npj Systems Biology and Applications (Nature Portfolio), 2026. The gSage® engine outperformed three alternative AI architectures on all five evaluation measures, across 375 clinician questions and 5 cancer types.
BUILT ON TRUST
Every recommendation cited to its source, with confidence levels and gaps named. Built on openly-licensed knowledge, with HIPAA-aligned privacy and validated pipelines. Designed to support, not replace, the oncologist.
GROWING WITH THE COMMUNITY
Validation studies and oncologist pilots in progress across leading cancer health systems, with growing relationships among hospitals, physicians, and medical associations.
Three generations. One direction.
GeneSilico defines what comes next.
Every regimen, computed for this patient before a single dose is given.
LEADERSHIP
Co-founders, operators, scientists, and builders — united by a mission
to give every cancer patient the therapy that actually works for their
tumor.
Chief Executive Officer
Chief Technology Officer
Chief Science Officer
Chief Product Officer
Chief Operating Officer
VP of Finance
Head of R&D
Director of Sales India
Oncologists, hospitals, investors, and researchers, let’s talk
